JPWO2019198099A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019198099A5 JPWO2019198099A5 JP2020555449A JP2020555449A JPWO2019198099A5 JP WO2019198099 A5 JPWO2019198099 A5 JP WO2019198099A5 JP 2020555449 A JP2020555449 A JP 2020555449A JP 2020555449 A JP2020555449 A JP 2020555449A JP WO2019198099 A5 JPWO2019198099 A5 JP WO2019198099A5
- Authority
- JP
- Japan
- Prior art keywords
- preparation
- antibody
- controls
- salt
- stable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201841013645 | 2018-04-10 | ||
| IN201841013645 | 2018-04-10 | ||
| PCT/IN2019/050291 WO2019198099A1 (en) | 2018-04-10 | 2019-04-10 | Stable antibody formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521168A JP2021521168A (ja) | 2021-08-26 |
| JP2021521168A5 JP2021521168A5 (https=) | 2022-04-15 |
| JPWO2019198099A5 true JPWO2019198099A5 (https=) | 2022-04-15 |
Family
ID=68164052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555449A Pending JP2021521168A (ja) | 2018-04-10 | 2019-04-10 | 安定な抗体製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12024561B2 (https=) |
| EP (1) | EP3773695A4 (https=) |
| JP (1) | JP2021521168A (https=) |
| CN (1) | CN112243379A (https=) |
| AU (1) | AU2019251452A1 (https=) |
| BR (1) | BR112020020741A2 (https=) |
| CO (1) | CO2020013545A2 (https=) |
| SG (1) | SG11202009872YA (https=) |
| WO (1) | WO2019198099A1 (https=) |
| ZA (1) | ZA202006262B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024249568A1 (en) | 2023-05-30 | 2024-12-05 | Paragon Therapeutics, Inc. | Alpha4beta7 integrin antibody compositions and methods of use |
| CN121889424A (zh) | 2023-08-14 | 2026-04-17 | 派拉冈医疗公司 | α4β7整联蛋白结合蛋白及使用方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2358763C2 (ru) * | 2003-02-10 | 2009-06-20 | Элан Фармасьютикалз, Инк. | Композиции иммуноглобулина и способ их получения |
| US20090208492A1 (en) * | 2007-06-14 | 2009-08-20 | Elan Pharmaceuticals, Inc. | Lyophilized Immunoglobulin Formulations and Methods of Preparation |
| WO2009141239A1 (en) * | 2008-05-20 | 2009-11-26 | F. Hoffmann-La Roche Ag | A pharmaceutical formulation comprising an antibody against ox40l, uses thereof |
| AR076640A1 (es) * | 2009-03-06 | 2011-06-29 | Genentech Inc | Formulacion con anticuerpo. metodo para estabilizar anticuerpo. articulo de manufactura |
| UA116189C2 (uk) * | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА |
| DK3311834T3 (da) * | 2011-05-02 | 2026-04-20 | Millennium Pharmaceuticals Inc | Formulering til anti-alfa4beta7-antistof |
| AU2019251453A1 (en) * | 2018-04-10 | 2020-11-26 | Dr. Reddy’S Laboratories Limited | Stable formulations of therapeutic antibody |
| US12030948B2 (en) * | 2018-04-10 | 2024-07-09 | Dr. Reddy's Laboratories Limited | Antibody formulation |
| US20220267449A1 (en) * | 2019-06-10 | 2022-08-25 | Takeda Pharmaceutical Company Limited | METHODS OF PRODUCING AN ANTI-a4B7 ANTIBODY |
| AU2020290999A1 (en) * | 2019-06-10 | 2022-02-03 | Takeda Pharmaceutical Company Limited | Antibody purification methods and compositions thereof |
-
2019
- 2019-04-10 AU AU2019251452A patent/AU2019251452A1/en not_active Abandoned
- 2019-04-10 BR BR112020020741-1A patent/BR112020020741A2/pt not_active IP Right Cessation
- 2019-04-10 US US17/045,336 patent/US12024561B2/en active Active
- 2019-04-10 WO PCT/IN2019/050291 patent/WO2019198099A1/en not_active Ceased
- 2019-04-10 SG SG11202009872YA patent/SG11202009872YA/en unknown
- 2019-04-10 CN CN201980038032.1A patent/CN112243379A/zh active Pending
- 2019-04-10 EP EP19785443.3A patent/EP3773695A4/en active Pending
- 2019-04-10 JP JP2020555449A patent/JP2021521168A/ja active Pending
-
2020
- 2020-10-08 ZA ZA2020/06262A patent/ZA202006262B/en unknown
- 2020-10-28 CO CONC2020/0013545A patent/CO2020013545A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2532475C (en) | Formulation for a protein pharmaceutical without added human serum albumin (hsa) | |
| JPWO2019217927A5 (https=) | ||
| US2795529A (en) | Stabilized hyaluronidase solution containing calcium chloride | |
| JP2021521159A5 (https=) | ||
| TW509576B (en) | Pharmaceutical composition containing human growth hormone | |
| RU2005128280A (ru) | Композиции иммуноглобулина и способ их получения | |
| EP3681483B1 (en) | Process for lyophilized pharmaceutical formulation of a therapeutic protein | |
| TWI653048B (zh) | 含有肉毒桿菌毒素的穩定液體組合物 | |
| CA2742659C (en) | Aqueous composition containing follicle-stimulating hormone | |
| JP2021521171A5 (https=) | ||
| MY206282A (en) | Protein solution formulation containing high concentration of an anti-vegf antibody | |
| JPWO2019198100A5 (https=) | ||
| JP2021521168A5 (https=) | ||
| JPWO2019198099A5 (https=) | ||
| JPWO2023063376A5 (https=) | ||
| JPWO2019198101A5 (https=) | ||
| EP3178927B1 (en) | Protein-stabilizing agent and protein-stabilizing method | |
| EP3373953B1 (fr) | Composition a action rapide d'insuline comprenant un citrate substitue | |
| JP2009203223A (ja) | 凍結乾燥用保護剤及び生理活性物質の製造方法 | |
| AU784885B2 (en) | Dry compositions containing hydrophobic amino acid | |
| JPS6059000A (ja) | インタ−フェロンの安定化方法 | |
| RU2218934C2 (ru) | Препарат интерферона | |
| JP5323036B2 (ja) | タンパク質水溶液の保存方法 | |
| JP2009023934A (ja) | 凍結乾燥方法 | |
| RU2024113529A (ru) | Составы |